91 related articles for article (PubMed ID: 19781904)
1. Hemodynamic effects of recombinant human activated protein C in patients with septic shock.
Sanchez B; Piacentini E; Pradella V; Mignini M; Nava J
J Crit Care; 2010 Jun; 25(2):343-7. PubMed ID: 19781904
[TBL] [Abstract][Full Text] [Related]
2. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
[TBL] [Abstract][Full Text] [Related]
3. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
[TBL] [Abstract][Full Text] [Related]
4. Rapid and beneficial hemodynamic effects of activated protein C in septic shock patients.
Monnet X; Lamia B; Anguel N; Richard C; Bonmarchand G; Teboul JL
Intensive Care Med; 2005 Nov; 31(11):1573-6. PubMed ID: 16175347
[TBL] [Abstract][Full Text] [Related]
5. Use of activated protein C in liver transplantation patients with septic shock.
Rinaldi L; Marietta M; Mignini MA; Donno L; Busani S; Codeluppi M; Masetti M; Girardis M
Liver Transpl; 2008 Nov; 14(11):1598-602. PubMed ID: 18972572
[TBL] [Abstract][Full Text] [Related]
6. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock.
Kirschenbaum LA; Lopez WC; Ohrum P; Tsen A; Khazin J; Astiz ME
Crit Care Med; 2006 Aug; 34(8):2207-12. PubMed ID: 16775572
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of therapy with recombinant human activated protein C of critically ill surgical patients with infection complicated by septic shock and multiple organ dysfunction syndrome.
Barie PS; Hydo LJ; Shou J; Eachempati SR
Surg Infect (Larchmt); 2011 Dec; 12(6):443-9. PubMed ID: 22185191
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis.
Lindenauer PK; Rothberg MB; Nathanson BH; Pekow PS; Steingrub JS
Crit Care Med; 2010 Apr; 38(4):1101-7. PubMed ID: 20154607
[TBL] [Abstract][Full Text] [Related]
10. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
[TBL] [Abstract][Full Text] [Related]
11. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
Lam SW; Bauer SR; Cha SS; Oyen LJ
Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis.
Maybauer MO; Maybauer DM; Fraser JF; Traber LD; Westphal M; Enkhbaatar P; Cox RA; Huda R; Hawkins HK; Morita N; Murakami K; Mizutani A; Herndon DN; Traber DL
Crit Care Med; 2006 Sep; 34(9):2432-8. PubMed ID: 16810106
[TBL] [Abstract][Full Text] [Related]
13. Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock.
Ataman K; Jehmlich M; Kock S; Neumann S; Leischik M; Filipovic Z; Hopf HB
Intensive Care Med; 2002 Aug; 28(8):1164-7. PubMed ID: 12185443
[TBL] [Abstract][Full Text] [Related]
14. [Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and pro-inflammatory cytokines in patients with refractory septic shock].
Wang CT; Ren HS; Jiang JJ; Zhang JC; Meng M; Yu JB; Chu YF; Ding M
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jul; 21(7):421-4. PubMed ID: 19615135
[TBL] [Abstract][Full Text] [Related]
15. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients.
Raurich JM; Llompart-Pou JA; Ibáñez J; Frontera G; Pérez O; García L; Ayestarán JI
J Crit Care; 2007 Dec; 22(4):324-9. PubMed ID: 18086404
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of recombinant human activated protein C in a ewe model of septic shock.
Wang Z; Su F; Rogiers P; Vincent JL
Crit Care Med; 2007 Nov; 35(11):2594-600. PubMed ID: 17901839
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study.
Bauer SR; Aloi JJ; Ahrens CL; Yeh JY; Culver DA; Reddy AJ
J Crit Care; 2010 Jun; 25(2):362.e7-362.e11. PubMed ID: 19926252
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
19. Activated protein C in septic shock: a propensity-matched analysis.
Sadaka F; O'Brien J; Migneron M; Stortz J; Vanston A; Taylor RW
Crit Care; 2011; 15(2):R89. PubMed ID: 21385410
[TBL] [Abstract][Full Text] [Related]
20. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
Morelli A; Lange M; Ertmer C; Broeking K; Van Aken H; Orecchioni A; Rocco M; Bachetoni A; Traber DL; Landoni G; Pietropaoli P; Westphal M
Shock; 2007 Nov; 28(5):530-5. PubMed ID: 17589379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
